• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Fresenius Kabi launches sodium chloride injection in Freeflex IV bags

April 21, 2021 By Sean Whooley

Fresenius Kabi Heparin sodium Freeflex IV bags
[Image from Fresenius Kabi]
Fresenius Kabi announced today that it launched two new presentations of Heparin sodium in its Freeflex IV bags.

Lake Zurich, Ill.–based Fresenius Kabi’s Heparin sodium in sodium chloride injection at a concentration of two USP units per ml is indicated as an anticoagulant to maintain catheter patency, according to a news release.

Available in two strengths (1,000 USP units in 0.9% sodium chloride 500 mL infusion bag/2,000 USP unites in 0.9% sodium chloride 1,000 ml infusion bag), the heparin sodium is delivered with Fresenius Kabi’s convenient, ready-to-administer Freeflex IV bags.

Freeflex is a multilayer, polyolefin film container designed to reduce end users’ steps compared to using vials with leak-resistant technology and an easy-to-handle design for infusion therapies.

In addition to the Freeflex premixed bags, Heparin sodium therapies are also offered in Fresenius Kabi’s Simplist prefilled syringes and vials.

“In line with our commitment to offering convenient, ready-to-administer products to help minimize drug errors and assure patient safety, we are pleased to introduce a low concentration option in our line of Heparin Sodium in Sodium Chloride,” Fresenius Kabi USA president & CEO John Ducker said in the release. “We remain focused on meeting clinicians’ needs by expanding the variety of presentations of products we offer in Freeflex IV bags and Simplist prefilled syringes.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: freseniuskabi

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS